Pérol M - Search Results

1

Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors.

Saboundji K, Auliac JB, Pérol M, François G, Janicot H, Marcq M, Dubos-Arvis C, Renault A, Guisier F, Odier L, Gervais R, Chouaïd C. Saboundji K, et al. Among authors: perol m. Target Oncol. 2018 Aug;13(4):501-507. doi: 10.1007/s11523-018-0581-2. Target Oncol. 2018. PMID: 30039345

2

[Phase II study of docetaxel in inoperable advanced non small cell lung cancer].

Robinet G, Thomas P, Pérol M, Vergnenegre A, Lena H, Taytard A, Paillotin D, Bessa EH, Schuller-Lebeau MP. Robinet G, et al. Among authors: perol m. Bull Cancer. 2000 Mar;87(3):253-8. Bull Cancer. 2000. PMID: 10779813 Free article. Clinical Trial. French.

3

[First-line treatment of metastatic non-small cell lung cancers].

Pérol M. Pérol M. Rev Pneumol Clin. 2004 Nov;60(5 Pt 2):3S51-6. Rev Pneumol Clin. 2004. PMID: 15536354 Review. French.

4

[Chemotherapy for metastatic non-small cell lung cancer].

Pérol M, Moro-Sibilot D. Pérol M, et al. Rev Mal Respir. 2005 Dec;22(6 Pt 2):8S131-6. Rev Mal Respir. 2005. PMID: 16340849 Review. French.

5

Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: a GLOT-GFPC study.

Cortot AB, Gerinière L, Robinet G, Breton JL, Corre R, Falchero L, Berard H, Gimenez C, Chavaillon JM, Perol M, Bombaron P, Mercier C, Souquet PJ; Groupe Lyon-Saint-Etienne d'Oncologie Thoracique; Groupe Français de Pneumo-Cancérologie. Cortot AB, et al. Among authors: perol m. Ann Oncol. 2006 Sep;17(9):1412-7. doi: 10.1093/annonc/mdl146. Epub 2006 Jun 21. Ann Oncol. 2006. PMID: 16790516 Free article. Clinical Trial.

6

Economic impact of gefitinib for refractory non-small-cell lung cancer: a Markov model-based analysis.

Chouaid C, Monnet I, Robinet G, Perol M, Fournel P, Vergnenegre A. Chouaid C, et al. Among authors: perol m. Curr Med Res Opin. 2007 Jul;23(7):1509-15. doi: 10.1185/030079907x199718. Curr Med Res Opin. 2007. PMID: 17559745

7

An open multicenter phase II trial of docetaxel-gemcitabine in Charlson score and performance status (PS) selected elderly patients with stage IIIB pleura/IV non-small-cell lung cancer (NSCLC): the GFPC 02-02a study.

LeCaer H, Fournel P, Jullian H, Chouaid C, Letreut J, Thomas P, Paillotin D, Perol M, Gimenez C, Vergnenegre A. LeCaer H, et al. Among authors: perol m. Crit Rev Oncol Hematol. 2007 Oct;64(1):73-81. doi: 10.1016/j.critrevonc.2007.06.008. Epub 2007 Jul 31. Crit Rev Oncol Hematol. 2007. PMID: 17669664 Clinical Trial.

8

[Angiogenesis and lung cancer].

Pérol M, Arpin D. Pérol M, et al. Bull Cancer. 2007 Jul;94 Spec No:S220-31. Bull Cancer. 2007. PMID: 17846008 Review. French.

9

[Tyrosine kinase inhibitors in the management of non-small cell lung cancer].

Pérol M, Arpin D. Pérol M, et al. Rev Mal Respir. 2007 Oct;24(8 Pt 2):6S188-97. Rev Mal Respir. 2007. PMID: 18235413 Review. French.

10

[How to treat the relapse of NSCLC after surgery and chemotherapy? IFTC 0702 randomized phase III study].

Moro-Sibilot D, Barlesi F, Timsit JF, Debieuvre D, Fournel P, Gervais R, Mazieres J, Milleron B, Morin F, Perol M, Soria JC, Souquet PJ, Vergnenègre A, Zalcman G. Moro-Sibilot D, et al. Among authors: perol m. Rev Mal Respir. 2008 Jan;25(1):91-6. doi: 10.1016/s0761-8425(08)70474-1. Rev Mal Respir. 2008. PMID: 18288059 Clinical Trial. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

269 results

Search Page